Skip to content

Pillboxes should be standard issue for HIV patients, study concludes

A follow-up on follow-up: shifting to a community-based response to improve retention in care

Heavy drinkers living with HIV have lower CD4 counts

Emergence of CXCR4-tropic HIV raises risk of AIDS fourfold

Start treatment at 500 or 350? UK cohort data show clear difference in risk of death

HIV/HCV coinfected patients who develop severe allergy to nevirapine have significantly increased risk of death

Viral load during primary infection influences viral load for years after

Use CD4 cell count, not CD4 cell percentage to guide treatment decisions in all patients with HIV, even those with cirrhosis

IAS: Boosted atazanavir shows edge over unboosted in treatment-naive after 96 weeks